Brief: Cipher Pharmaceuticals Says A-101 40 Pct Topical Solution Accepted For Review By Health Canada
18/12/2018 12:07
Dec 18 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS ANNOUNCES A-101 40% TOPICAL
SOLUTION
ACCEPTED FOR REVIEW BY HEALTH CANADA
Source text for Eikon: ID:nCNWfCgfla
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million